Vanberra Signal

Pathogenomix

Curated by Signal

Solution for bacterial identification by DNA sequencing

Overview

Pathogenomix offers solutions for sequence based analysis to identify infectious pathogens, in pure- or poly-microbial samples. RipSeq is a SaaS solution which claims to uses algorithms to process targeted NGS sequence file locally, and reduce the information needed to upload by a factor of 1000:1, while still retaining resolution and specificity. Ripseq DB is a curated pathogen database where databases are filtered and automatically curated. It also enables users to curate a more medically-relevant reference database. Users can annotate, reject and approve references using personalized methods. RipSeq Sanger products can be used for mono and poly microbial samples and users can also perform bulk analysis.

Key facts

Founded
2015

Business model

Contact

More on Vanberra Signal

Members only
  • Market Intelligence tool for the alcoholic beverage industry

    Enterprise Software & InfrastructureChicago, United States
  • Job Board for physicians

    Enterprise Software & InfrastructureChicago, United States
  • Provider of a cloud-based end-to-end IoT platform

    Enterprise Software & InfrastructureLos Altos, United States

About Pathogenomix

What does Pathogenomix do?

Pathogenomix offers solutions for sequence based analysis to identify infectious pathogens, in pure- or poly-microbial samples.

Where is Pathogenomix headquartered?

Pathogenomix is headquartered in Santa Cruz, United States.

When was Pathogenomix founded?

Pathogenomix was founded in 2015.

Which sector is Pathogenomix in?

Pathogenomix operates in Enterprise Software & Infrastructure.

Who are Pathogenomix's competitors?

Companies similar to Pathogenomix include BevAnalytics, HiredMD, and Afero.